SCHEMBL4366394

SCHEMBL4366394

COC(=O)C(CCS)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 4/20 0.36
CPB2 Q96IY4 4/20 0.36
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
THRB P10828 1/20 0.34
POLB P06746 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 1/20 0.32
CA14 Q9ULX7 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TP53 P04637 1/20 0.31
ZDHHC7 Q9NXF8 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL990377 0.84 CPN1 (0.44) CPN1CPB2CHRNB2CHRNB4CHRNA3
SCHEMBL27866752 0.81 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4THRB
SCHEMBL9644387 0.78 ZDHHC7 (0.51) CA1CA2TSHRZDHHC7
SCHEMBL28720058 0.78 THRB (0.37) CHRNB2CHRNB4CHRNA3CHRNA4THRB
SCHEMBL30801437 0.77 ZDHHC7 (0.54) CA1CA2TSHRZDHHC7
SCHEMBL774185 0.77 ZDHHC7 (0.39) CPN1CPB2CHRNB2CHRNB4CHRNA3
SCHEMBL5493664 0.76 THRB (0.36) CPN1CPB2CHRNB2CHRNB4CHRNA3
SCHEMBL26828326 0.76 THRB (0.40) THRBCA1CA2TSHRSMN1; SMN2
SCHEMBL3908306 0.74 SMN1; SMN2 (0.42) THRBCA1CA2TSHRSMN1; SMN2
SCHEMBL10256655 0.73 TP53 (0.41) THRBCA1CA2TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114889-A1 METHOD OF PREPARING MONTELUKAST AND INTERMEDIATES USED THEREIN Hanmi Pharm. Co., Ltd. (KR) 2009-11-11 EP disclosed
WO-2008072872-A1 METHOD OF PREPARING MONTELUKAST AND INTERMEDIATES USED THEREIN HANMI PHARM. CO., LTD. (KR) 2008-06-19 WO disclosed